Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, shared Thomas Ichim’s, President and Chief Scientific Officer at Immorta Bio, shared a post on X:
“What a forward looking organization Aetna!
Congratulations on addressing the administrative burden of doctors looking after patients with cancer and instituting a modernized oncology prior authorization system. The potential for patients and their doctors accessing state of the art clinical trials as a ‘trial match’ is now real.”
